Skip to main content
Caplight Logo









Nervotec

Nervotec

Private
SingaporeHealthcare & Life Scienceshttps://nervotec.com/

Last Round

Seed

May 31, 2023

Company Overview

Nervotec is a healthcare technology company that develops contactless, remote health parameter measurement software using rPPG technology and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Computer Vision, InsurTech, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

contactless biosensingremote photoplethysmographyrPPGvital sign monitoringhealth AIcomputer vision healthtelemedicineinsurtechhealthcare as a serviceHaaSdigital healthremote patient monitoringRPMsdk integrationbiometric scanningface-based health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nervotec Comparables

Compare Nervotec with similar companies based on industry and business-model similarity.

Nervotec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shen AI
91%
NuraLogix
91%
PanopticAI
90%

Nervotec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 31, 2023
AcceleratorNov 8, 2022

Nervotec Investors

Notable investors and investment history

Nervotec investors
InvestorRounds
Mercatus CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2022

    Received funding from Huawei Cloud.

Recent news

Latest coverage and updates

  • launchesJun 23, 2026

    Nervotec Pte. Ltd. launched NervoScan MCP on Jun 23rd '26.

Nervotec Filings

Explore SEC and related filing metadata, where available.

Nervotec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nervotec's valuation, stock price, and market status.

Is Nervotec a public or private company?

Nervotec is a private company.

What is the current stock price of Nervotec?

Nervotec is a private company with no public stock price. No recent secondary market data is available.

How much is Nervotec worth (valuation)?

Valuation information for Nervotec is not publicly available.

Can I buy Nervotec stock?

Nervotec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nervotec's last funding round?

Nervotec's most recent funding round was Seed on May 31, 2023.

Who are the main investors in Nervotec?

Key investors in Nervotec include Mercatus Capital.

Will Nervotec IPO soon?

No public IPO plans have been announced for Nervotec.

How can I track Nervotec secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nervotec's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range7
Year Founded2020
Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?